H2020Individual fellowship2020–2022

CATKERB · Total Syntheses of Catharanthine and Keramaphidin B by an Iridium-Catalyzed Reductive Cyclization Cascade

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2020-08-03 → 2022-08-02
EU contribution
€212,934
Participants
1
Scheme
MSCA-IF-EF-ST

Lines connect the coordinator with its partners.

Results in brief

Total Syntheses of Catharanthine and Keramaphidin B by an Iridium-Catalyzed Reductive Cyclization Cascade

Introduction: The functionalization of organic molecules with difluoro- and trifluoromethyl groups has gained considerable attention in pharmaceutical and agrochemical research as well as in material science due to the remarkable impact of fluorine atoms on the physical, chemical, and biological properties of the original molecule. More specifically, the β-fluorinated-α-amino motif represents a key building block in many bioactive molecules such as gemcitabine, GDC-0077, seletalisib, cevipabulin and LGD-2226 (Scheme 1A), owing to the electronic influence of the fluorine atoms on the neighboring nitrogen center. Therefore, the development of concise and selective methods for the introduction of fluorine-containing groups into various nitrogen-containing scaffolds is a highly desirable target in synthetic organic chemistry. A well-known instrument to obtain β-fluorinated-α-amino compounds is the addition of nucleophilic di- or trifluoromethyl sources on to electrophilic species such as imines or nitriles and several methods have been developed to carry out these types of reactions. However, the direct nucleophilic di- or trifluoromethylation of the amide group ubiquitous in pharmaceutically active molecules and natural products remains extremely underdeveloped, which might constitute in the low electrophilicity of the amide group compared to the previously mentioned electrophiles. Nevertheless, there are a few sporadic reports by Brigaud, Leadbeater and Huang enabling the challenging direct trifluoromethylation of amides and overcoming this reactivity problem by either using already activated more electrophilic starting materials such as Weinreb-amides or N-Boc protected lactams or by using stoichiometric activating reagents such as triflic anhydride. Another general and highly chemoselective approach for amide functionalization can be achieved under reductive transition metal-catalyzed conditions as demonstrated by Dixon and others. Using catalytic amounts of rhodium or iridium complexes and silanes as reductants led to the formation of meta-stable O-silylated hemiaminal intermediates, which are precursors to reactive iminium ions that can undergo subsequent nucleophilic functionalization with various nucleophiles such as silylenolethers, isonitriles, allytributylstannane, trimethylsilyl cyanide, Grignard reagents, alkynes, and indoles. Surprisingly, to the best of our knowledge, only one seminal report by Huang includes two examples where they utilized this partial reduction approach of amides to incorporate the trifluoromethyl group, using the Ruppert-Prakash reagent (TMSCF3) and tetrabutylammonium difluorotriphenylsilicate (TBAT) to insitu generate the nucleophilic CF3-source. Objectives: Therefore, the overall objectives of this project can be summarized as follows: a) To develop general reductive transition metal-catalyzed di- and trifluoromethylations of tertiary amides and lactams to furnish valuable fluorinated cyclic and acyclic tertiary amines and b) to systematically apply these methods to the late-stage functionalization of various drugs and natural products to point out the great value of this reaction for medicinal chemistry and society (Scheme 1B). Conclusion: A broadly applicable and efficient method for the synthesis of acyclic and cyclic α-difluoroalkylated tertiary amines with good overall yields has been developed. The mild iridium-catalyzed reductive difluoroalkylation shows excellent functional group tolerance with respect to both coupling partners; amides/lactams and organozinc reagents, which is among other things highlighted by the late-stage derivatization of four drug molecules. Furthermore, the synthetic utility of this method was demonstrated by a satisfying performance on gram scale and several useful downstream functionalizations (Scheme 2).

Data: CORDIS, © European Union

Project objective

During the course of this Fellowship a reductive cyclization cascade for dihydropyridinones, which consists of an iridium-catalyzed reduction to the corresponding electron-rich dienes and subsequent [4+2] cycloaddition (Diels-Alder reaction) will be developed. A first promising proof of concept study establishing the feasibility of this powerful transformation has already been carried out in the Dixon group; however further optimization by varying the solvent, the reaction time, the temperature or by using suitable Lewis acids is required to perfect the methodology. The additional use of chiral Lewis acid or chiral amine catalysts is also intended to develop an enantioselective variant of this method. The methodology development should then be completed by determining the substrate scope. The resulting azabicyclo[2.2.2]octene motif is an important structural component of various alkaloids. Therefore, this reaction cascade should then be used as a late stage key step in the total syntheses of the natural products catharanthine and keramaphidin B.Catharanthine is an important member of the large class of iboga alkaloids, which usually carry as common structural feature an indole or an indoline moiety. Catharanthine can be considered as a direct precursor of the dimeric Catharanthus alkaloids vinblastine and vincristine, both of which are clinically valuable agents in the treatment of cancer due to their ability to inhibit mitosis the formation of microtubules.The marine alkaloid keramaphidin B belongs to the manzamine family and shows cytotoxicity against P388 leukaemia cells in mice (IC50 0.28 μg/mL) and against epidermal KB cancer cells in humans (IC50 0.30 μg/mL). Structurally, keramaphidin B is a pentacyclic compound comprising two piperidine rings (one bridged and one unbridged) and two macrocycles. Furthermore, this alkaloid has two (Z)-configured and one triple-substituted double bond, as well as four stereogenic centers, one of which is quaternary.

Original text from CORDIS.

Participants

  • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordCoordinatorUnited Kingdom

Links

Data: CORDIS, © European Union